BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fairlie DP, Tyndall JDA, Reid RC, Wong AK, Abbenante G, Scanlon MJ, March DR, Bergman DA, Chai CLL, Burkett BA. Conformational Selection of Inhibitors and Substrates by Proteolytic Enzymes:  Implications for Drug Design and Polypeptide Processing. J Med Chem 2000;43:1271-81. [DOI: 10.1021/jm990315t] [Cited by in Crossref: 121] [Cited by in F6Publishing: 107] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Ersmark K, Nervall M, Gutiérrez-de-Terán H, Hamelink E, Janka LK, Clemente JC, Dunn BM, Gogoll A, Samuelsson B, Qvist J, Hallberg A. Macrocyclic inhibitors of the malarial aspartic proteases plasmepsin I, II, and IV. Bioorg Med Chem 2006;14:2197-208. [PMID: 16307884 DOI: 10.1016/j.bmc.2005.11.003] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
2 Zückert WR, Kerentseva TA, Lawson CL, Barbour AG. Structural Conservation of Neurotropism-associated VspA within the Variable Borrelia Vsp-OspC Lipoprotein Family. Journal of Biological Chemistry 2001;276:457-63. [DOI: 10.1074/jbc.m008449200] [Cited by in Crossref: 38] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
3 Noel AF, Bilsel O, Kundu A, Wu Y, Zitzewitz JA, Matthews CR. The folding free-energy surface of HIV-1 protease: insights into the thermodynamic basis for resistance to inhibitors. J Mol Biol 2009;387:1002-16. [PMID: 19150359 DOI: 10.1016/j.jmb.2008.12.061] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
4 Deng JZ, McMasters DR, Rabbat PM, Williams PD, Coburn CA, Yan Y, Kuo LC, Lewis SD, Lucas BJ, Krueger JA, Strulovici B, Vacca JP, Lyle TA, Burgey CS. Development of an oxazolopyridine series of dual thrombin/factor Xa inhibitors via structure-guided lead optimization. Bioorg Med Chem Lett 2005;15:4411-6. [PMID: 16137886 DOI: 10.1016/j.bmcl.2005.07.022] [Cited by in Crossref: 35] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
5 Lang SA, Kozyukov AV, Balakin KV, Skorenko AV, Ivashchenko AA, Savchuk NP. Classification scheme for the design of serine protease targeted compound libraries. J Comput Aided Mol Des 2002;16:803-7. [PMID: 12825792 DOI: 10.1023/a:1023832728547] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
6 Lee H, Boyer NC, Deng Q, Kim HY, Sawyer TK, Sciammetta N. Photoredox Ni-catalyzed peptide C(sp2)-O cross-coupling: from intermolecular reactions to side chain-to-tail macrocyclization. Chem Sci 2019;10:5073-8. [PMID: 31183058 DOI: 10.1039/c9sc00694j] [Cited by in Crossref: 24] [Cited by in F6Publishing: 3] [Article Influence: 8.0] [Reference Citation Analysis]
7 Chappell KJ, Nall TA, Stoermer MJ, Fang N, Tyndall JD, Fairlie DP, Young PR. Site-directed Mutagenesis and Kinetic Studies of the West Nile Virus NS3 Protease Identify Key Enzyme-Substrate Interactions. Journal of Biological Chemistry 2005;280:2896-903. [DOI: 10.1074/jbc.m409931200] [Cited by in Crossref: 49] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
8 Naqvi T, Lim A, Rouhani R, Singh R, Eglen RM. Galactosidase Enzyme Fragment Complementation as a High-Throughput Screening Protease Technology. J Biomol Screen 2004;9:398-408. [DOI: 10.1177/1087057104264040] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
9 Smith JM, Hill NC, Krasniak PJ, Fasan R. Synthesis of bicyclic organo-peptide hybrids via oxime/intein-mediated macrocyclization followed by disulfide bond formation. Org Biomol Chem 2014;12:1135-42. [PMID: 24395107 DOI: 10.1039/c3ob42222d] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 1.9] [Reference Citation Analysis]
10 Liotta LA, Medina I, Robinson JL, Carroll CL, Pan P, Corral R, Johnston JV, Cook KM, Curtis FA, Sharples GJ, Mcalpine SR. Novel antibiotics: second generation macrocyclic peptides designed to trap Holliday junctions. Tetrahedron Letters 2004;45:8447-50. [DOI: 10.1016/j.tetlet.2004.09.084] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
11 Sgambelluri RM, Smith MO, Walton JD. Versatility of Prolyl Oligopeptidase B in Peptide Macrocyclization. ACS Synth Biol 2017;7:145-52. [DOI: 10.1021/acssynbio.7b00264] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
12 Somavarapu AK, Kepp KP. Membrane Dynamics of γ-Secretase Provides a Molecular Basis for β-Amyloid Binding and Processing. ACS Chem Neurosci 2017;8:2424-36. [DOI: 10.1021/acschemneuro.7b00208] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 7.0] [Reference Citation Analysis]
13 Jiang Y, Li BQ, Zhang Y, Feng YM, Gao YF, Zhang N, Cai YD. Prediction and Analysis of Post-Translational Pyruvoyl Residue Modification Sites from Internal Serines in Proteins. PLoS One 2013;8:e66678. [PMID: 23805260 DOI: 10.1371/journal.pone.0066678] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
14 Morewood R, Nitsche C. A biocompatible stapling reaction for in situ generation of constrained peptides. Chem Sci 2020;12:669-74. [PMID: 34163798 DOI: 10.1039/d0sc05125j] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
15 Tyndall JDA, Reid RC, Tyssen DP, Jardine DK, Todd B, Passmore M, March DR, Pattenden LK, Bergman DA, Alewood D, Hu S, Alewood PF, Birch CJ, Martin JL, Fairlie DP. Synthesis, Stability, Antiviral Activity, and Protease-Bound Structures of Substrate-Mimicking Constrained Macrocyclic Inhibitors of HIV-1 Protease. J Med Chem 2000;43:3495-504. [DOI: 10.1021/jm000013n] [Cited by in Crossref: 54] [Cited by in F6Publishing: 41] [Article Influence: 2.5] [Reference Citation Analysis]
16 Hanessian S, Brassard M. Stereoselective synthesis of constrained oxacyclic hydroxyethylene isosteres of aspartyl protease inhibitors. Nitroaldol methodology toward 2,3-substituted tetrahydrofurans. Tetrahedron 2004;60:7621-8. [DOI: 10.1016/j.tet.2004.06.060] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
17 Le GT, Abbenante G, Madala PK, Hoang HN, Fairlie DP. Organic Azide Inhibitors of Cysteine Proteases. J Am Chem Soc 2006;128:12396-7. [DOI: 10.1021/ja0637649] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
18 Tyndall JDA, Pfeiffer B, Abbenante G, Fairlie DP. Over One Hundred Peptide-Activated G Protein-Coupled Receptors Recognize Ligands with Turn Structure. Chem Rev 2005;105:793-826. [DOI: 10.1021/cr040689g] [Cited by in Crossref: 172] [Cited by in F6Publishing: 158] [Article Influence: 10.1] [Reference Citation Analysis]
19 Di Pietro ME, Aroulanda C, Merlet D, Celebre G, De Luca G. Conformational Investigation in Solution of a Fluorinated Anti-inflammatory Drug by NMR Spectroscopy in Weakly Ordering Media. J Phys Chem B 2014;118:9007-16. [DOI: 10.1021/jp505084g] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
20 Smith JM, Vitali F, Archer SA, Fasan R. Modular Assembly of Macrocyclic Organo-Peptide Hybrids Using Synthetic and Genetically Encoded Precursors. Angew Chem 2011;123:5181-6. [DOI: 10.1002/ange.201101331] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
21 Mak CC, Le V, Lin Y, Elder JH, Wong C. Design, synthesis, and biological evaluation of HIV/FIV protease inhibitors incorporating a conformationally constrained macrocycle with a small P3′ residue. Bioorganic & Medicinal Chemistry Letters 2001;11:219-22. [DOI: 10.1016/s0960-894x(00)00641-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
22 Chappell KJ, Stoermer MJ, Fairlie DP, Young PR. Insights to Substrate Binding and Processing by West Nile Virus NS3 Protease through Combined Modeling, Protease Mutagenesis, and Kinetic Studies. Journal of Biological Chemistry 2006;281:38448-58. [DOI: 10.1074/jbc.m607641200] [Cited by in Crossref: 74] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
23 Aroulanda C, Lesot P. Molecular enantiodiscrimination by NMR spectroscopy in chiral oriented systems: Concept, tools, and applications. Chirality 2021. [PMID: 34936130 DOI: 10.1002/chir.23386] [Reference Citation Analysis]
24 Sengupta S, Mehta G. Macrocyclization via C-H functionalization: a new paradigm in macrocycle synthesis. Org Biomol Chem 2020;18:1851-76. [PMID: 32101232 DOI: 10.1039/c9ob02765c] [Cited by in Crossref: 19] [Cited by in F6Publishing: 2] [Article Influence: 9.5] [Reference Citation Analysis]
25 Tian Y, Zhang S, Yin H, Yan A. Quantitative structure-activity relationship (QSAR) models and their applicability domain analysis on HIV-1 protease inhibitors by machine learning methods. Chemometrics and Intelligent Laboratory Systems 2020;196:103888. [DOI: 10.1016/j.chemolab.2019.103888] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
26 Stoermer MJ, Chappell KJ, Liebscher S, Jensen CM, Gan CH, Gupta PK, Xu W, Young PR, Fairlie DP. Potent Cationic Inhibitors of West Nile Virus NS2B/NS3 Protease With Serum Stability, Cell Permeability and Antiviral Activity. J Med Chem 2008;51:5714-21. [DOI: 10.1021/jm800503y] [Cited by in Crossref: 64] [Cited by in F6Publishing: 59] [Article Influence: 4.6] [Reference Citation Analysis]
27 Mak CC, Brik A, Lerner DL, Elder JH, Morris GM, Olson AJ, Wong C. Design and synthesis of broad-Based mono- and bi- cyclic inhibitors of FIV and HIV proteases. Bioorganic & Medicinal Chemistry 2003;11:2025-40. [DOI: 10.1016/s0968-0896(03)00054-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
28 Armoush N, Syal P, Becker DP. Synthesis of Substituted 2‐Amino‐cyclobutanones. Synthetic Communications 2008;38:1679-87. [DOI: 10.1080/00397910801981110] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
29 Maurizio C, Flavio R, Maria Enrica DP, Elena T, Giuseppina DL. Conformational features of 4-(N)-squalenoyl-gemcitabine in solution: a combined NMR and molecular dynamics investigation. New J Chem 2015;39:3484-96. [DOI: 10.1039/c4nj02091j] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
30 Makatini MM, Petzold K, Alves CN, Arvidsson PI, Honarparvar B, Govender P, Govender T, Kruger HG, Sayed Y, JerônimoLameira, Maguire GE, Soliman ME. Synthesis, 2D-NMR and molecular modelling studies of pentacycloundecane lactam-peptides and peptoids as potential HIV-1 wild type C-SA protease inhibitors. J Enzyme Inhib Med Chem 2013;28:78-88. [PMID: 22339087 DOI: 10.3109/14756366.2011.633907] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
31 Le GT, Abbenante G, Fairlie DP. Profiling the enzymatic properties and inhibition of human complement factor B. J Biol Chem 2007;282:34809-16. [PMID: 17921140 DOI: 10.1074/jbc.M705646200] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
32 Yeo JG, Leong J, Arkachaisri T, Cai Y, Teo BH, Tan JH, Das L, Lu J. Proteolytic inactivation of nuclear alarmin high-mobility group box 1 by complement protease C1s during apoptosis. Cell Death Discov 2016;2:16069. [PMID: 27648302 DOI: 10.1038/cddiscovery.2016.69] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
33 Gu Y, Iannuzzelli JA, Fasan R. MOrPH-PhD: A Phage Display System for the Functional Selection of Genetically Encoded Macrocyclic Peptides. Methods Mol Biol 2022;2371:261-86. [PMID: 34596853 DOI: 10.1007/978-1-0716-1689-5_14] [Reference Citation Analysis]
34 Loughlin WA, Tyndall JDA, Glenn MP, Fairlie DP. Beta-Strand Mimetics. Chem Rev 2004;104:6085-118. [DOI: 10.1021/cr040648k] [Cited by in Crossref: 179] [Cited by in F6Publishing: 163] [Article Influence: 9.9] [Reference Citation Analysis]
35 Ranatunga S, Liyanage W, Del Valle JR. Synthesis and conformational analysis of bicyclic extended dipeptide surrogates. J Org Chem 2010;75:5113-25. [PMID: 20593836 DOI: 10.1021/jo1008433] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
36 Aleksandrov A, Simonson T. Molecular dynamics simulations show that conformational selection governs the binding preferences of imatinib for several tyrosine kinases. J Biol Chem 2010;285:13807-15. [PMID: 20200154 DOI: 10.1074/jbc.M110.109660] [Cited by in Crossref: 62] [Cited by in F6Publishing: 30] [Article Influence: 5.2] [Reference Citation Analysis]
37 Huizing AP, Mondal M, Hirsch AK. Fighting malaria: structure-guided discovery of nonpeptidomimetic plasmepsin inhibitors. J Med Chem 2015;58:5151-63. [PMID: 25719272 DOI: 10.1021/jm5014133] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 3.1] [Reference Citation Analysis]
38 Kahler U, Fuchs JE, Goettig P, Liedl KR. An unexpected switch in peptide binding mode: from simulation to substrate specificity. J Biomol Struct Dyn 2018;36:4072-84. [PMID: 29210603 DOI: 10.1080/07391102.2017.1407674] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
39 Schmidt B. Aspartic proteases involved in Alzheimer's disease. Chembiochem 2003;4:366-78. [PMID: 12740808 DOI: 10.1002/cbic.200200532] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
40 Chen H, Jiao W, Jones MA, Coxon JM, Morton JD, Bickerstaffe R, Pehere AD, Zvarec O, Abell AD. New tripeptide-based macrocyclic calpain inhibitors formed by N-alkylation of histidine. Chem Biodivers 2012;9:2473-84. [PMID: 23161629 DOI: 10.1002/cbdv.201200320] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
41 Frémont M, El Bakkouri K, Vaeyens F, Herst CV, De Meirleir K, Englebienne P. 2',5'-Oligoadenylate size is critical to protect RNase L against proteolytic cleavage in chronic fatigue syndrome. Exp Mol Pathol 2005;78:239-46. [PMID: 15924878 DOI: 10.1016/j.yexmp.2005.01.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
42 Glenn MP, Pattenden LK, Reid RC, Tyssen DP, Tyndall JD, Birch CJ, Fairlie DP. Beta-strand mimicking macrocyclic amino acids: templates for protease inhibitors with antiviral activity. J Med Chem 2002;45:371-81. [PMID: 11784141 DOI: 10.1021/jm010414i] [Cited by in Crossref: 58] [Cited by in F6Publishing: 42] [Article Influence: 2.9] [Reference Citation Analysis]
43 Moneriz C, Mestres J, Bautista JM, Diez A, Puyet A. Multi-targeted activity of maslinic acid as an antimalarial natural compound. FEBS J 2011;278:2951-61. [PMID: 21689375 DOI: 10.1111/j.1742-4658.2011.08220.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
44 Shepherd NE, Hoang HN, Abbenante G, Fairlie DP. Single turn peptide alpha helices with exceptional stability in water. J Am Chem Soc 2005;127:2974-83. [PMID: 15740134 DOI: 10.1021/ja0456003] [Cited by in Crossref: 227] [Cited by in F6Publishing: 200] [Article Influence: 13.4] [Reference Citation Analysis]
45 Theron LW, Divol B. Microbial aspartic proteases: current and potential applications in industry. Appl Microbiol Biotechnol 2014;98:8853-68. [PMID: 25269600 DOI: 10.1007/s00253-014-6035-6] [Cited by in Crossref: 52] [Cited by in F6Publishing: 32] [Article Influence: 6.5] [Reference Citation Analysis]
46 Tyndall JD, Nall T, Fairlie DP. Proteases universally recognize beta strands in their active sites. Chem Rev 2005;105:973-99. [PMID: 15755082 DOI: 10.1021/cr040669e] [Cited by in Crossref: 295] [Cited by in F6Publishing: 268] [Article Influence: 17.4] [Reference Citation Analysis]
47 Bursavich MG, West CW, Rich DH. From Peptides to Non-Peptide Peptidomimetics:  Design and Synthesis of New Piperidine Inhibitors of Aspartic Peptidases. Org Lett 2001;3:2317-20. [DOI: 10.1021/ol016092u] [Cited by in Crossref: 49] [Cited by in F6Publishing: 36] [Article Influence: 2.3] [Reference Citation Analysis]
48 Ng NM, Pierce JD, Webb GI, Ratnikov BI, Wijeyewickrema LC, Duncan RC, Robertson AL, Bottomley SP, Boyd SE, Pike RN. Discovery of Amino Acid Motifs for Thrombin Cleavage and Validation Using a Model Substrate. Biochemistry 2011;50:10499-507. [DOI: 10.1021/bi201333g] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
49 Abell AD, Brown KM, Coxon JM, Jones MA, Miyamoto S, Neffe AT, Nikkel JM, Stuart BG. Synthesis and evaluation of eight-membered cyclic pseudo-dipeptides. Peptides 2005;26:251-8. [DOI: 10.1016/j.peptides.2004.09.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
50 Di Pietro ME, Celebre G, Salvino RA, Aroulanda C, Merlet D, De Luca G. The use of residual dipolar couplings for conformational analysis of non-steroidal anti-inflammatory drugs dissolved in weakly ordering media. Liquid Crystals 2018;45:2033-47. [DOI: 10.1080/02678292.2018.1499975] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
51 Löser R, Abbenante G, Madala PK, Halili M, Le GT, Fairlie DP. Noncovalent Tripeptidyl Benzyl- and Cyclohexyl-Amine Inhibitors of the Cysteine Protease Caspase-1. J Med Chem 2010;53:2651-5. [DOI: 10.1021/jm901790w] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
52 Lohman RJ, Harrison RS, Ruiz-Gómez G, Hoang HN, Shepherd NE, Chow S, Hill TA, Madala PK, Fairlie DP. Helix-constrained nociceptin peptides are potent agonists and antagonists of ORL-1 and nociception. Vitam Horm 2015;97:1-55. [PMID: 25677767 DOI: 10.1016/bs.vh.2014.10.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
53 Harrison RS, Sharpe PC, Singh Y, Fairlie DP. Amyloid peptides and proteins in review. Rev Physiol Biochem Pharmacol 2007;159:1-77. [PMID: 17846922 DOI: 10.1007/112_2007_0701] [Cited by in Crossref: 42] [Cited by in F6Publishing: 70] [Article Influence: 2.8] [Reference Citation Analysis]
54 Silva RN, Oliveira LCG, Parise CB, Oliveira JR, Severino B, Corvino A, di Vaio P, Temussi PA, Caliendo G, Santagada V, Juliano L, Juliano MA. Activity of human kallikrein-related peptidase 6 (KLK6) on substrates containing sequences of basic amino acids. Is it a processing protease? Biochim Biophys Acta Proteins Proteom 2017;1865:558-64. [PMID: 28254587 DOI: 10.1016/j.bbapap.2017.02.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
55 Iannuzzelli JA, Fasan R. Expanded toolbox for directing the biosynthesis of macrocyclic peptides in bacterial cells. Chem Sci 2020;11:6202-8. [PMID: 32953014 DOI: 10.1039/d0sc01699c] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
56 Gupta S, Payne J. Evaluation of the conformational propensities of peptide isosteres as a basis for selecting bioactive pseudopeptides: Peptide isosteres. The Journal of Peptide Research 2001;58:546-61. [DOI: 10.1034/j.1399-3011.2001.00954.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
57 Frost JR, Vitali F, Jacob NT, Brown MD, Fasan R. Macrocyclization of Organo-Peptide Hybrids through a Dual Bio-orthogonal Ligation: Insights from Structure-Reactivity Studies. ChemBioChem 2013;14:147-60. [DOI: 10.1002/cbic.201200579] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
58 Nall TA, Chappell KJ, Stoermer MJ, Fang N, Tyndall JD, Young PR, Fairlie DP. Enzymatic Characterization and Homology Model of a Catalytically Active Recombinant West Nile Virus NS3 Protease. Journal of Biological Chemistry 2004;279:48535-42. [DOI: 10.1074/jbc.m406810200] [Cited by in Crossref: 96] [Cited by in F6Publishing: 31] [Article Influence: 5.3] [Reference Citation Analysis]
59 Willert M, Benito JM, Meldal M. Solid-Phase Combinatorial Library of Norstatine-Type Isosters by the Nitroaldol Reaction. J Comb Chem 2003;5:91-101. [DOI: 10.1021/cc0100722] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
60 Stuart BG, Coxon JM, Morton JD, Abell AD, Mcdonald DQ, Aitken SG, Jones MA, Bickerstaffe R. Molecular Modeling: A Search for a Calpain Inhibitor as a New Treatment for Cataractogenesis. J Med Chem 2011;54:7503-22. [DOI: 10.1021/jm200471r] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
61 Li D, Ji B. Protein conformational transitions coupling with ligand interactions: Simulations from molecules to medicine. Medicine in Novel Technology and Devices 2019;3:100026. [DOI: 10.1016/j.medntd.2019.100026] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
62 Malde AK, Hill TA, Iyer A, Fairlie DP. Crystal Structures of Protein-Bound Cyclic Peptides. Chem Rev 2019;119:9861-914. [DOI: 10.1021/acs.chemrev.8b00807] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 9.0] [Reference Citation Analysis]
63 Li BQ, Cai YD, Feng KY, Zhao GJ. Prediction of protein cleavage site with feature selection by random forest. PLoS One 2012;7:e45854. [PMID: 23029276 DOI: 10.1371/journal.pone.0045854] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
64 Smith JM, Vitali F, Archer SA, Fasan R. Modular assembly of macrocyclic organo-peptide hybrids using synthetic and genetically encoded precursors. Angew Chem Int Ed Engl 2011;50:5075-80. [PMID: 21506227 DOI: 10.1002/anie.201101331] [Cited by in Crossref: 51] [Cited by in F6Publishing: 41] [Article Influence: 4.6] [Reference Citation Analysis]
65 Boyd SE, Pike RN, Rudy GB, Whisstock JC, Garcia de la Banda M. PoPS: a computational tool for modeling and predicting protease specificity. J Bioinform Comput Biol 2005;3:551-85. [PMID: 16108084 DOI: 10.1142/s021972000500117x] [Cited by in Crossref: 70] [Cited by in F6Publishing: 33] [Article Influence: 4.1] [Reference Citation Analysis]
66 Ibrahim MIA, Zhou Z, Deng C, Didierjean C, Vanderesse R, Bodiguel J, Averlant-petit M, Jamart-grégoire B. Impact of C α -Chirality on Supramolecular Self-Assembly in Cyclo-2:1-[α/aza]-Hexamers ( d / l -Phe-azaPhe-Ala) 2: Impact of C α -Chirality on Supramolecular Self-Assembly in Cyclo-2:1-[α/aza]-Hexamers ( d / l -Phe-azaPhe-Ala) 2. Eur J Org Chem 2017;2017:4703-12. [DOI: 10.1002/ejoc.201700555] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
67 Reid RC, Pattenden LK, Tyndall JDA, Martin JL, Walsh T, Fairlie DP. Countering Cooperative Effects in Protease Inhibitors Using Constrained β-Strand-Mimicking Templates in Focused Combinatorial Libraries. J Med Chem 2004;47:1641-51. [DOI: 10.1021/jm030337m] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 2.2] [Reference Citation Analysis]
68 Ruiz-Gómez G, Lim J, Halili MA, Le GT, Madala PK, Abbenante G, Fairlie DP. Structure-activity relationships for substrate-based inhibitors of human complement factor B. J Med Chem 2009;52:6042-52. [PMID: 19743866 DOI: 10.1021/jm900781m] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
69 Rohrbacher F, Deniau G, Luther A, Bode JW. Spontaneous head-to-tail cyclization of unprotected linear peptides with the KAHA ligation. Chem Sci 2015;6:4889-96. [PMID: 29142720 DOI: 10.1039/c5sc01774b] [Cited by in Crossref: 25] [Cited by in F6Publishing: 4] [Article Influence: 3.6] [Reference Citation Analysis]
70 Brayden DJ, Hill TA, Fairlie DP, Maher S, Mrsny RJ. Systemic delivery of peptides by the oral route: Formulation and medicinal chemistry approaches. Adv Drug Deliv Rev 2020;157:2-36. [PMID: 32479930 DOI: 10.1016/j.addr.2020.05.007] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 20.0] [Reference Citation Analysis]
71 Tyndall JDA, Pattenden LK, Reid RC, Hu S, Alewood D, Alewood PF, Walsh T, Fairlie DP, Martin JL. Crystal Structures of Highly Constrained Substrate and Hydrolysis Products Bound to HIV-1 Protease. Implications for the Catalytic Mechanism. Biochemistry 2008;47:3736-44. [DOI: 10.1021/bi7023157] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
72 Marsault E, Peterson ML. Macrocycles Are Great Cycles: Applications, Opportunities, and Challenges of Synthetic Macrocycles in Drug Discovery. J Med Chem 2011;54:1961-2004. [DOI: 10.1021/jm1012374] [Cited by in Crossref: 522] [Cited by in F6Publishing: 439] [Article Influence: 47.5] [Reference Citation Analysis]
73 Hill TA, Shepherd NE, Diness F, Fairlie DP. Fixierung cyclischer Peptide: Mimetika von Proteinstrukturmotiven. Angew Chem 2014;126:13234-57. [DOI: 10.1002/ange.201401058] [Cited by in Crossref: 66] [Cited by in F6Publishing: 48] [Article Influence: 8.3] [Reference Citation Analysis]
74 D de Araujo A, Lim J, Wu KC, Xiang Y, Good AC, Skerlj R, Fairlie DP. Bicyclic Helical Peptides as Dual Inhibitors Selective for Bcl2A1 and Mcl-1 Proteins. J Med Chem 2018;61:2962-72. [PMID: 29584430 DOI: 10.1021/acs.jmedchem.8b00010] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 6.5] [Reference Citation Analysis]
75 Ode H, Yokoyama M, Kanda T, Sato H. Identification of folding preferences of cleavage junctions of HIV-1 precursor proteins for regulation of cleavability. J Mol Model 2011;17:391-9. [PMID: 20480379 DOI: 10.1007/s00894-010-0739-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
76 Quéléver G, Bihel F, Kraus JL. New beta-strand macrocyclic peptidomimetic analogues containing alpha-(O-, S- or NH-)aryl substituted glycine residues: synthesis, chemical and enzymatic properties. Org Biomol Chem 2003;1:1676-83. [PMID: 12926354 DOI: 10.1039/b211644h] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
77 Braun HA, Meusinger R, Schmidt B. 2-Iodoethanols from aldehydes, diiodomethane and isopropylmagnesium chloride. Tetrahedron Letters 2005;46:2551-4. [DOI: 10.1016/j.tetlet.2005.02.093] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
78 Graven A, St Hilaire PM, Sanderson SJ, Mottram JC, Coombs GH, Meldal M. Combinatorial library of peptide isosters based on Diels-Alder reactions: identification of novel inhibitors against a recombinant cysteine protease from Leishmania mexicana. J Comb Chem 2001;3:441-52. [PMID: 11549362 DOI: 10.1021/cc0001102] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 1.3] [Reference Citation Analysis]
79 Bolla ML, Azevedo EV, Smith JM, Taylor RE, Ranjit DK, Segall AM, Mcalpine SR. Novel Antibiotics:  Macrocyclic Peptides Designed to Trap Holliday Junctions. Org Lett 2003;5:109-12. [DOI: 10.1021/ol020204f] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
80 Belfrage AK, Gising J, Svensson F, Åkerblom E, Sköld C, Sandström A. Efficient and Selective Palladium-Catalysed C-3 Urea Couplings to 3,5-Dichloro-2(1 H )-pyrazinones: Palladium-Catalysed Urea Couplings. Eur J Org Chem 2015;2015:978-86. [DOI: 10.1002/ejoc.201403405] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
81 Örtqvist P, Gising J, Ehrenberg AE, Vema A, Borg A, Karlén A, Larhed M, Danielson UH, Sandström A. Discovery of achiral inhibitors of the hepatitis C virus NS3 protease based on 2(1H)-pyrazinones. Bioorganic & Medicinal Chemistry 2010;18:6512-25. [DOI: 10.1016/j.bmc.2010.06.101] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
82 Rich DH, Bursavich MG, Estiarte MA. Discovery of nonpeptide, peptidomimetic peptidase inhibitors that target alternate enzyme active site conformations. Biopolymers 2002;66:115-25. [DOI: 10.1002/bip.10231] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
83 Lima AR, Juliano L, Juliano MA. Cyclic, linear, cycloretro-isomer, and cycloretro-inverso peptides derived from the C-terminal sequence of bradykinin as substrates or inhibitors of serine and cysteine proteases. Protein J 2004;23:287-94. [PMID: 15214499 DOI: 10.1023/b:jopc.0000027853.93513.34] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
84 Rao T, Ruiz-Gómez G, Hill TA, Hoang HN, Fairlie DP, Mason JM. Truncated and helix-constrained peptides with high affinity and specificity for the cFos coiled-coil of AP-1. PLoS One 2013;8:e59415. [PMID: 23544065 DOI: 10.1371/journal.pone.0059415] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 4.2] [Reference Citation Analysis]
85 Weerawarna PM, Kim Y, Galasiti Kankanamalage AC, Damalanka VC, Lushington GH, Alliston KR, Mehzabeen N, Battaile KP, Lovell S, Chang KO, Groutas WC. Structure-based design and synthesis of triazole-based macrocyclic inhibitors of norovirus protease: Structural, biochemical, spectroscopic, and antiviral studies. Eur J Med Chem 2016;119:300-18. [PMID: 27235842 DOI: 10.1016/j.ejmech.2016.04.013] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
86 Smith JM, Fasan R. Synthesis of macrocyclic organo-peptide hybrids from ribosomal polypeptide precursors via CuAAC-/hydrazide-mediated cyclization. Methods Mol Biol 2015;1248:23-38. [PMID: 25616323 DOI: 10.1007/978-1-4939-2020-4_2] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
87 Kamenik AS, Kraml J, Hofer F, Waibl F, Quoika PK, Kahler U, Schauperl M, Liedl KR. Macrocycle Cell Permeability Measured by Solvation Free Energies in Polar and Apolar Environments. J Chem Inf Model 2020;60:3508-17. [PMID: 32551643 DOI: 10.1021/acs.jcim.0c00280] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
88 Sergeant GE, Jolliffe KA. Anion recognition using a simple cyclic peptide. Supramolecular Chemistry 2020;32:233-7. [DOI: 10.1080/10610278.2020.1732377] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
89 Carbonell T, Masip I, Sánchez-baeza F, Delgado M, Araya E, Llorens O, Corcho F, Pérez JJ, Pérez-payá E, Messeguer A. . Molecular Diversity;5:131-43. [DOI: 10.1023/a:1016230600162] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
90 Frost JR, Jacob NT, Papa LJ, Owens AE, Fasan R. Ribosomal Synthesis of Macrocyclic Peptides in Vitro and in Vivo Mediated by Genetically Encoded Aminothiol Unnatural Amino Acids. ACS Chem Biol 2015;10:1805-16. [PMID: 25933125 DOI: 10.1021/acschembio.5b00119] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 4.4] [Reference Citation Analysis]
91 Makatini MM, Petzold K, Sriharsha SN, Ndlovu N, Soliman ME, Honarparvar B, Parboosing R, Naidoo A, Arvidsson PI, Sayed Y, Govender P, Maguire GE, Kruger HG, Govender T. Synthesis and structural studies of pentacycloundecane-based HIV-1 PR inhibitors: A hybrid 2D NMR and docking/QM/MM/MD approach. European Journal of Medicinal Chemistry 2011;46:3976-85. [DOI: 10.1016/j.ejmech.2011.05.071] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
92 Srivastava V, Saxena HO, Shanker K, Kumar J, Luqman S, Gupta M, Khanuja S, Negi AS. Synthesis of gallic acid based naphthophenone fatty acid amides as cathepsin D inhibitors. Bioorganic & Medicinal Chemistry Letters 2006;16:4603-8. [DOI: 10.1016/j.bmcl.2006.06.010] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
93 Illingworth CJR, Scott PD, Parkes KEB, Snell CR, Campbell MP, Reynolds CA. Connectivity and binding-site recognition: Applications relevant to drug design. J Comput Chem 2010;31:2677-88. [DOI: 10.1002/jcc.21561] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
94 Oliveira LC, Silva VO, Okamoto DN, Kondo MY, Santos SM, Hirata IY, Vallim MA, Pascon RC, Gouvea IE, Juliano MA, Juliano L. Internally quenched fluorescent peptide libraries with randomized sequences designed to detect endopeptidases. Anal Biochem 2012;421:299-307. [PMID: 22067978 DOI: 10.1016/j.ab.2011.10.025] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
95 Loughlin WA, Tyndall JDA, Glenn MP, Hill TA, Fairlie DP. Update 1 of: Beta-Strand Mimetics. Chem Rev 2010;110:PR32-69. [DOI: 10.1021/cr900395y] [Cited by in Crossref: 79] [Cited by in F6Publishing: 71] [Article Influence: 7.2] [Reference Citation Analysis]
96 Fouché M, Schäfer M, Berghausen J, Desrayaud S, Blatter M, Piéchon P, Dix I, Martin garcia A, Roth H. Design and Development of a Cyclic Decapeptide Scaffold with Suitable Properties for Bioavailability and Oral Exposure. ChemMedChem 2016;11:1048-59. [DOI: 10.1002/cmdc.201600082] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 6.3] [Reference Citation Analysis]
97 Frost JR, Wu Z, Lam YC, Owens AE, Fasan R. Side-chain-to-tail cyclization of ribosomally derived peptides promoted by aryl and alkyl amino-functionalized unnatural amino acids. Org Biomol Chem 2016;14:5803-12. [PMID: 27064594 DOI: 10.1039/c6ob00192k] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
98 Owens AE, Iannuzzelli JA, Gu Y, Fasan R. MOrPH-PhD: An Integrated Phage Display Platform for the Discovery of Functional Genetically Encoded Peptide Macrocycles. ACS Cent Sci 2020;6:368-81. [PMID: 32232137 DOI: 10.1021/acscentsci.9b00927] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 9.5] [Reference Citation Analysis]
99 Madala PK, Tyndall JDA, Nall T, Fairlie DP. Update 1 of: Proteases Universally Recognize Beta Strands In Their Active Sites. Chem Rev 2010;110:PR1-PR31. [DOI: 10.1021/cr900368a] [Cited by in Crossref: 118] [Cited by in F6Publishing: 106] [Article Influence: 10.7] [Reference Citation Analysis]
100 Fairlie DP. Small Molecules that Mimic Components of Bioactive Protein Surfaces. Aust J Chem 2004;57:855. [DOI: 10.1071/ch04074] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
101 Song J, Tan H, Boyd SE, Shen H, Mahmood K, Webb GI, Akutsu T, Whisstock JC, Pike RN. Bioinformatic approaches for predicting substrates of proteases. J Bioinform Comput Biol 2011;9:149-78. [PMID: 21328711 DOI: 10.1142/s0219720011005288] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
102 Makatini MM, Petzold K, Sriharsha SN, Soliman ME, Honarparvar B, Arvidsson PI, Sayed Y, Govender P, Maguire GE, Kruger HG, Govender T. Pentacycloundecane-based inhibitors of wild-type C-South African HIV-protease. Bioorg Med Chem Lett 2011;21:2274-7. [PMID: 21429747 DOI: 10.1016/j.bmcl.2011.02.105] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
103 Gohda K. A quantitative structure-activity relationship study for structurally diverse HIV-1 protease inhibitors: Contribution of conformational flexibility to inhibitory activity. J Enzyme Inhib Med Chem 2006;21:609-15. [PMID: 17194035 DOI: 10.1080/14756360600810233] [Reference Citation Analysis]
104 Hill TA, Shepherd NE, Diness F, Fairlie DP. Constraining cyclic peptides to mimic protein structure motifs. Angew Chem Int Ed Engl 2014;53:13020-41. [PMID: 25287434 DOI: 10.1002/anie.201401058] [Cited by in Crossref: 260] [Cited by in F6Publishing: 215] [Article Influence: 32.5] [Reference Citation Analysis]
105 Gorrão SS, Hemerly JP, Lima AR, Melo RL, Szeltner Z, Polgár L, Juliano MA, Juliano L. Fluorescence resonance energy transfer (FRET) peptides and cycloretro-inverso peptides derived from bradykinin as substrates and inhibitors of prolyl oligopeptidase. Peptides 2007;28:2146-54. [PMID: 17904692 DOI: 10.1016/j.peptides.2007.08.018] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
106 Gordon DJ, Tappe R, Meredith SC. Design and characterization of a membrane permeable N-methyl amino acid-containing peptide that inhibits Abeta1-40 fibrillogenesis. J Pept Res 2002;60:37-55. [PMID: 12081625 DOI: 10.1034/j.1399-3011.2002.11002.x] [Cited by in Crossref: 108] [Cited by in F6Publishing: 104] [Article Influence: 5.7] [Reference Citation Analysis]
107 Smith JM, Frost JR, Fasan R. Emerging strategies to access peptide macrocycles from genetically encoded polypeptides. J Org Chem 2013;78:3525-31. [PMID: 23517465 DOI: 10.1021/jo400119s] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
108 Ruzindana-Umunyana A, Weber JM. Interactions of human lacrimal and salivary cystatins with adenovirus endopeptidase. Antiviral Res 2001;51:203-14. [PMID: 11448731 DOI: 10.1016/s0166-3542(01)00154-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
109 Ersmark K, Samuelsson B, Hallberg A. Plasmepsins as potential targets for new antimalarial therapy. Med Res Rev 2006;26:626-66. [PMID: 16838300 DOI: 10.1002/med.20082] [Cited by in Crossref: 119] [Cited by in F6Publishing: 103] [Article Influence: 7.9] [Reference Citation Analysis]
110 Oppewal TR, Jansen ID, Hekelaar J, Mayer C. A Strategy to Select Macrocyclic Peptides Featuring Asymmetric Molecular Scaffolds as Cyclization Units by Phage Display. J Am Chem Soc 2022. [PMID: 35171585 DOI: 10.1021/jacs.1c12822] [Reference Citation Analysis]
111 Chandrasekhar S, Sudhakar A, Kiran MU, Babu BN, Jagadeesh B. β-Strand mimetics: formation of bend-strands in oligomers of enantiomeric β-amino acids. Tetrahedron Letters 2008;49:7368-71. [DOI: 10.1016/j.tetlet.2008.10.031] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
112 Baran I, Varekova RS, Parthasarathi L, Suchomel S, Casey F, Shields DC. Identification of Potential Small Molecule Peptidomimetics Similar to Motifs in Proteins. J Chem Inf Model 2007;47:464-74. [DOI: 10.1021/ci600404q] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
113 Arasappan A, Chen KX, Njoroge FG, Parekh TN, Girijavallabhan V. Novel dipeptide macrocycles from 4-oxo, -thio, and -amino-substituted proline derivatives. J Org Chem 2002;67:3923-6. [PMID: 12027716 DOI: 10.1021/jo011160b] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
114 Patil NA, Quek JP, Schroeder B, Morewood R, Rademann J, Luo D, Nitsche C. 2-Cyanoisonicotinamide Conjugation: A Facile Approach to Generate Potent Peptide Inhibitors of the Zika Virus Protease. ACS Med Chem Lett 2021;12:732-7. [PMID: 34055219 DOI: 10.1021/acsmedchemlett.0c00657] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
115 Reid RC, Kelso MJ, Scanlon MJ, Fairlie DP. Conformationally Constrained Macrocycles That Mimic Tripeptide β-Strands in Water and Aprotic Solvents. J Am Chem Soc 2002;124:5673-83. [DOI: 10.1021/ja0256461] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 2.4] [Reference Citation Analysis]
116 Kang CW, Sun Y, Del Valle JR. Substituted imidazo[1,2-a]pyridines as β-strand peptidomimetics. Org Lett 2012;14:6162-5. [PMID: 23210770 DOI: 10.1021/ol302850n] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]